Clinical trial
IRIS: Use of Implantable Defibrillator in High-risk Patients Early After Acute…
NCT00157768 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00157768 |
|---|---|
| Title | IRIS : Use of Implantable Defibrillator in High-risk Patients Early After Acute Myocardial Infarction |
| Official title | IRIS - Immediate Risk-stratification Improves Survival - Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK) |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Device |
| Interventions | Implantable cardioverter defibrillator |
| Enrollment | 900 |
| Start date | Jun 9, 1999 |
| Primary completion | Oct 15, 2007 |
| Completion | Oct 15, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 3, 2025 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: